Clinical Trials News Update – May 27, 2009
This is my site Written by Alex on May 27, 2009 – 10:01 am   

FDA, Clinical Trial Updates: Genzyme, Human Genome Sciences, Eli Seeking Alpha – New York, NY,USA – Eli Lilly (LLY): On 5/21/09, LLY announced that it will begin enrolling patients this month in two separate but identical Phase 3 clinical trials of … See all stories on this topic

Cholesterol drug cuts amputation risk for diabeticsReuters – USA – led by Anthony Keech and Kushwin Rajamani at the National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Australia. … See all stories on this topic

NIH announces new program to develop therapeutics for rare and EurekAlert (press release) – Washington, DC, USA – Only if these stages are successful can a potential treatment move to clinical trials in patients. Unfortunately, the success rate in this preclinical … See all stories on this topic

Participation in clinical trials empowering for reporter in fight The Plain Dealer – cleveland.comCleveland, OH, USA – The Web site gives easy access to information on clinical trials for a wide range of diseases and conditions. … See all stories on this topic

New Partnership Provides Single Source for Cognitive Analysis ofBusiness Wire (press release) – San Francisco, CA, USA – Provident’s mission is to advance the science of chronic disease prevention by designing and conducting clinical trials. In addition to working with CDR on … See all stories on this topic

Somaxon Pharmaceuticals Presents Silenor Clinical Data at the APA Trading Markets (press release) – Los Angeles, CA, USA – The four posters represent a subset of the data from Somaxon’s completed clinical development program, which comprised four Phase 3 clinical trials … See all stories on this topic

FDA, Clinical Trial Updates: Heart Stents, Cholesterol in the News – Forex Hound – New York, NY, USA – The results of the NEVO RES I study comparing these two drug-eluting stents were presented during Late Breaking Clinical Trials at EuroPCR … See all stories on this topic

FDA, Clinical Trial Updates: GENZ, HGSI, LLY, NGSXForex Hound – New York, NY, USA – In 2008, Lilly began enrolling patients in two Phase 3 clinical trials called IDENTITY and IDENTITY 2 for a different potential treatment for Alzheimer’s … See all stories on this topic  

Leave a Reply

You must be logged in to post a comment.